Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: The homing of bone marrow stem cells is differentially activated in ischemic and valvular heart diseases and influenced by beta-blockers

Fig. 4

Influence of medications on the SDF-1 levels in cardiac patients. Ischemic heart disease (IHD) and valvular heart disease (VHD) patients had SDF-1 levels analyzed comparing the use (+) or not (−) of acetylsalicylic acid (ASA, a), angiotensin-converting enzyme inhibitors (ACEi, b), beta-blockers (BB, c), calcium-channels blockers (CCB, d), or statins (e). *VHD + BB vs. VHD − BB, P = 0.023

Back to article page
\